Skip to main content

Animations

MJFF Publications

3521 - 3530 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2021
  • 2018
  • 2023
  • 2023
  • 2014
  • 2021
  • 2025
  • 2016
  • 2017
  • Summary Details
    OPEN
    Title: The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0077-5
    Citation Count: 40
  • Summary Details
    RESTRICTED
    Title: Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.005
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.02.031
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Population fraction of Parkinson’s disease attributable to preventable risk factors
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00603-z
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1038/gim.2014.55
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Measuring Structural Racism: A Guide for Epidemiologists and Other Health Researchers
    Journal Name: American Journal of Epidemiology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/aje/kwab239
    Citation Count: 299
  • Summary Details
    OPEN
    Title: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70030
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Olfactory impairment predicts cognitive decline in early Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.013
    Citation Count: 111
  • Summary Details
    OPEN
    Title: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.201798099
    Citation Count: 351
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.